Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cancer

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1469324

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1469324

Cancer Research Technologies Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Description

Table of Contents

List of Tables

The cancer research technologies market is expected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2032, propelled by key drivers, including the transformative impact of genomics and proteomics technologies, advancements in imaging for early detection, and the promise of liquid biopsy technologies. However, ethical considerations surrounding emerging technologies present a notable restraint. Market segmentation reveals the dominance of genomics technologies, cancer diagnosis as a leading research area, specific cancer types, and academic and research institutions as prominent end-users. North America stands out as the leading geographic segment, with a robust competitive landscape characterized by innovation and strategic collaborations among major players. The market is poised for continued growth, driven by technological advancements and a collective effort to unravel the complexities of cancer for improved diagnostics and treatment strategies.

Key Market Drivers

Genomics Technologies Driving Precision Medicine

The adoption of genomics technologies has revolutionized cancer research, offering insights into the genetic basis of cancers and paving the way for personalized treatment strategies. Advancements in next-generation sequencing (NGS) technologies, such as whole-genome sequencing and RNA sequencing, have enabled a comprehensive understanding of genetic alterations in tumors. This has significantly improved patient outcomes by tailoring treatments based on individual genetic profiles.

Proteomics Technologies Unraveling Molecular Signatures

Proteomics technologies play a pivotal role in deciphering the complex molecular signatures of cancers. Techniques like mass spectrometry and protein microarrays enable the identification and quantification of proteins involved in cancer pathways. The integration of proteomics data with genomics information enhances the understanding of disease mechanisms and facilitates the discovery of novel therapeutic targets. This contributes to advancing targeted therapies and improving the effectiveness of cancer treatments.

Imaging Technologies Enhancing Early Detection

Advancements in imaging technologies, including positron emission tomography (PET) and magnetic resonance imaging (MRI), have bolstered early cancer detection and monitoring. These technologies provide detailed insights into tumor characteristics and aid in assessing treatment response. Evidence-based research underscores the role of imaging technologies in reducing the time to diagnosis, enabling timely interventions, and ultimately improving patient outcomes.

Restraint: Ethical Considerations in Emerging Technologies

The ethical implications surrounding emerging technologies, particularly in areas like liquid biopsy and gene editing, pose a significant restraint in the cancer research technologies market. Issues related to patient consent, data privacy, and the potential misuse of genetic information raise ethical concerns among researchers, clinicians, and the broader public. While these technologies hold immense promise, addressing ethical challenges is crucial for responsible and equitable advancement in cancer research.

Market Segmentation Analysis

Market by Technology: Genomics Dominate the Market

Various cutting-edge technologies, including Genomics Technologies, Proteomics Technologies, Imaging Technologies, Liquid Biopsy Technologies, and others propel the cancer research technologies market. Genomics Technologies emerged as the revenue leader, leveraging its pivotal role in advancing precision medicine and tailoring cancer treatments based on individual genetic profiles. The significant investments in genomic research, coupled with the increasing adoption of genomics in the research area of diagnosis and treatment, contribute to the high revenue in 2023. In terms of CAGR, Liquid Biopsy Technologies take the forefront, experiencing rapid growth due to their non-invasive nature and potential for early cancer detection, leading to a substantial expected increase in market share from 2024 to 2032.

Market by Research Area: Cancer Diagnosis Dominate the Market

Within the market's diverse research areas such as Cancer Diagnosis, Treatment Selection, Biomarker Discovery, Therapeutic Development, Cancer Epidemiology Research, Cancer Stem Cell Research, Radiation Oncology Advances, Functional Genomics in Cancer, Liquid Biopsy Applications, and Health Informatics in Cancer Research, Cancer Diagnosis claimed the highest revenue in 2023. This is primarily attributed to the critical role it plays in early detection and the subsequent personalized treatment of cancer patients. The high prevalence of cancer and the emphasis on early intervention contribute to the robust revenue figures in 2023. In terms of CAGR, Therapeutic Development emerges as a significant growth driver, reflecting the continuous efforts to develop novel and effective cancer treatments, with an anticipated surge in CAGR during the forecast period.

Market by Site of Cancer: Breast Cancer Dominates the Market

The segmentation based on the site of cancer covers a multitude of cancer types, each with its unique characteristics and research focus. Breast cancer remains the dominant in terms of revenues in 2023, reflecting its prevalence and substantial research investments. The high incidence of breast cancer globally, coupled with extensive research efforts directed toward understanding and treating this malignancy, contributes to its leading position in generating revenue for the market in 2023. In terms of CAGR, Pancreatic cancer stands out with a notable growth rate, driven by increased attention to this challenging and often lethal cancer type, leading to a substantial projected rise in CAGR from 2024 to 2032.

Market by End-User: Research Institutes Dominate the Market

End-users in the cancer research technologies market, including Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, and Hospitals, play pivotal roles in driving revenue. Academic and research institutions lead in revenue, emphasizing their central role in foundational research. The substantial funding received by research institutions, often from government grants and collaborations, contributes significantly to the overall high revenue of the market in 2023. In terms of CAGR, Pharmaceutical and Biotechnology Companies emerge as key drivers, with a projected significant increase during the forecast period, highlighting the growing collaboration between research institutions and industry players.

Market by Research Stage: Clinical Trials Stage Dominates the Market

Different research stages, encompassing Pre-clinical Research, Clinical Trials, Public Health Research, Cross-disciplinary Research, and General Cancer Research, contribute to the overall revenue of the cancer research technologies market. Clinical Trials dominate in terms of revenue, highlighting the pivotal role of rigorous testing in bringing novel cancer therapies to market. The high investment in clinical trial initiatives by pharmaceutical companies and research institutions contributes significantly to the market's robust revenue in 2023. In terms of CAGR, Cross-disciplinary Research exhibits a noteworthy growth rate, emphasizing the increasing importance of collaborative and interdisciplinary approaches to cancer research, with a projected surge in CAGR from 2024 to 2032.

North America Remains the Global Leader

The cancer research technologies market exhibits geographical variations that significantly impact both revenue distribution and expected CAGR. North America dominates the market in terms of revenue, driven by robust investments in cancer research, advanced healthcare infrastructure, and a high prevalence of cancer cases. The region's emphasis on translational research, strong collaborations between research institutions and industry players, and government initiatives supporting cancer research contribute to its leading revenue position in 2023. Meanwhile, Asia-Pacific is poised for the highest CAGR from 2024 to 2032, fueled by increasing awareness, rising cancer incidence, and a growing trend of outsourcing clinical trials and research activities to countries in this region. The strategic expansion of major market players and the establishment of research collaborations further contribute to the region's anticipated accelerated growth.

Market Competition to Intensify during the Forecast Period

The cancer research technologies market is characterized by intense competition among key players striving for innovation and market dominance. Leading companies such as Illumina Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche AG, QIAGEN, PerkinElmer Inc., Roche Diagnostics, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson and Company (BD), GE Healthcare, Siemens Healthineers, Abcam, GenScript Biotech Corporation, Merck KGaA, Cell Signaling Technology, and Sysmex Corporation are at the forefront, driving advancements in genomics technologies, diagnostic tools, and therapeutic interventions. Illumina's continuous efforts in developing cutting-edge sequencing technologies, Thermo Fisher Scientific's comprehensive portfolio of research solutions, and Roche's focus on precision medicine underscore their leadership positions. Strategic collaborations and partnerships are key trends in the market, fostering synergies between technology providers and healthcare institutions. For instance, Illumina's collaboration with major cancer centers enhances the integration of genomics data into clinical practice, facilitating personalized cancer treatments. Thermo Fisher Scientific's strategic partnerships with pharmaceutical companies strengthen its position in clinical trial support services. Roche's collaborations with academic institutions and research organizations contribute to the development of innovative cancer therapies. The competitive landscape is also marked by mergers and acquisitions, with major players seeking to expand their product portfolios and enhance their market presence. The acquisition of Genia by Roche and the merger of Thermo Fisher Scientific with QIAGEN exemplify strategic moves aimed at consolidating technological expertise and expanding research capabilities.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cancer Research Technologies market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Cancer Research Technologies market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Technology

    • Genomics Technologies
  • Next-Generation Sequencing (NGS)
    • Whole Genome Sequencing (WGS)
    • Whole Exome Sequencing (WES)
    • Targeted Sequencing
  • Polymerase Chain Reaction (PCR)
    • Real-Time PCR (qPCR)
    • Digital PCR (dPCR)
    • Reverse Transcription PCR (RT-PCR)
  • Microarray Technologies
    • DNA Microarrays
    • Protein Microarrays
    • Proteomics Technologies
  • Mass Spectrometry
    • Liquid Chromatography-Mass Spectrometry (LC-MS)
    • Matrix-Assisted Laser Desorption/Ionization (MALDI)
  • Protein Microarrays
    • Antibody Microarrays
    • Reverse Phase Protein Microarrays (RPPA)

2D Gel Electrophoresis

    • Two-Dimensional Polyacrylamide Gel Electrophoresis (2D PAGE)
    • Two-Dimensional Difference Gel Electrophoresis (2D-DIGE)
    • Imaging Technologies
  • Magnetic Resonance Imaging (MRI)
    • Functional MRI (fMRI)
    • Diffusion Weighted Imaging (DWI)
  • Computed Tomography (CT)
    • Low-Dose CT
    • Dual-Energy CT
  • Positron Emission Tomography (PET)
    • PET-CT
    • PET-MRI
  • Single-Photon Emission Computed Tomography (SPECT)
    • Liquid Biopsy Technologies
  • Circulating Tumor Cells (CTCs)
    • Microfluidic-Based CTC Isolation
    • Immunomagnetic CTC Isolation
  • Circulating Tumor DNA (ctDNA)
    • Targeted Sequencing of ctDNA
    • Methylation-Specific PCR (MSP)
  • Exosomes
    • Isolation and Characterization Techniques
    • Functional Analysis Methods
    • Others
  • Flow Cytometry
    • Fluorescence-Activated Cell Sorting (FACS)
    • Mass Cytometry (CyTOF)
  • In Situ Hybridization (ISH)
    • Fluorescence In Situ Hybridization (FISH)
    • Chromogenic In Situ Hybridization (CISH)
  • Immunohistochemistry (IHC)
    • Multiplex IHC
    • Digital Pathology IHC

Research Area

    • Cancer Diagnosis
  • Early Detection Technologies
    • Imaging-Based Early Detection
    • Liquid Biopsy for Early Detection
  • Diagnostic Biomarkers
    • Genomic Biomarkers
    • Proteomic Biomarkers
  • Pathological Diagnosis Advances
    • Digital Pathology
    • AI-Assisted Pathology
    • Treatment Selection
  • Precision Medicine Technologies
    • Molecular Profiling
    • Pharmacogenomics
  • Theranostics Approaches
    • Companion Diagnostics
    • Predictive Biomarkers
  • Immunotherapy Selection
    • Tumor Microenvironment Analysis
    • Immune Profiling
    • Biomarker Discovery
  • Genomic Biomarker Discovery
    • Whole Genome Sequencing (WGS) for Biomarkers
    • Transcriptomics for Biomarkers
  • Proteomic Biomarker Discovery
    • Mass Spectrometry-Based Biomarker Discovery
    • Protein Microarray-Based Biomarker Discovery
  • Metabolomics and Metabolic Biomarkers
    • Therapeutic Development
  • Targeted Therapy Research
    • Targeted Drug Discovery
    • Immunotherapy Development
  • Drug Efficacy Testing
    • In Vitro Testing Methods
    • In Vivo Testing Models
  • Gene Therapy and Gene Editing
    • CRISPR/Cas9 Applications
    • RNA Interference (RNAi) for Cancer
    • Cancer Epidemiology Research
  • Population-Level Studies
  • Environmental and Lifestyle Factors
  • Cancer Clusters Analysis
    • Cancer Stem Cell Research
  • Identification and Isolation Techniques
  • Targeted Therapies Against Cancer Stem Cells
    • Radiation Oncology Advances
  • Precision Radiation Therapy
  • Radiosensitization Strategies
  • Proton Therapy
    • Functional Genomics in Cancer
  • Functional Genomics Screening
  • CRISPR Functional Genomics
    • Liquid Biopsy Applications
  • Minimal Residual Disease Monitoring
  • Treatment Response Monitoring
  • Liquid Biopsy for Cancer Subtyping
    • Health Informatics in Cancer Research
  • Big Data Analytics
  • Electronic Health Records (EHR) Integration
  • Predictive Analytics for Cancer

Site of Cancer

    • Bladder
    • Bone
    • Brain
    • Breast
    • Cancer
    • Cervical
    • Cholangiocarcinoma
    • Colorectal
    • Haematological
    • Head and neck
    • Liver
    • Lung
    • Mesothelioma
    • Ovarian
    • Pancreatic
    • Prostate
    • Renal
    • Skin
    • Testicular
    • Thyroid
    • Upper gastrointestinal
    • Multiple cancers
    • Other

Research Stage

    • Pre-clinical research
    • Clinical Trials
    • Public Health Research
    • Cross-disciplinary research
    • General cancer research

End-User

    • Academic and Research Institutions
    • Pharmaceutical and Biotechnology Companies
    • Diagnostic Laboratories
    • Hospitals

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Cancer Research Technologies market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Cancer Research Technologies market?

Which is the largest regional market for Cancer Research Technologies market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Cancer Research Technologies market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Cancer Research Technologies market worldwide?

Show more
Product Code: 140210-04-24

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Cancer Research Technologies Market
  • 2.2. Global Cancer Research Technologies Market, By Technology, 2023 (US$ Million)
  • 2.3. Global Cancer Research Technologies Market, By Research Area, 2023 (US$ Million)
  • 2.4. Global Cancer Research Technologies Market, By Site of Cancer, 2023 (US$ Million)
  • 2.5. Global Cancer Research Technologies Market, By Research Stage, 2023 (US$ Million)
  • 2.6. Global Cancer Research Technologies Market, By End-User, 2023 (US$ Million)
  • 2.7. Global Cancer Research Technologies Market, By Geography, 2023 (US$ Million)
  • 2.8. Attractive Investment Proposition by Geography, 2023

3. Cancer Research Technologies Market: Competitive Analysis

  • 3.1. Market Positioning of Key Cancer Research Technologies Market Vendors
  • 3.2. Strategies Adopted by Cancer Research Technologies Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Cancer Research Technologies Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Cancer Research Technologies Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Genomics Technologies
      • 5.3.1.1. Next-Generation Sequencing (NGS)
        • 5.3.1.1.1. Whole Genome Sequencing (WGS)
        • 5.3.1.1.2. Whole Exome Sequencing (WES)
        • 5.3.1.1.3. Targeted Sequencing
      • 5.3.1.2. Polymerase Chain Reaction (PCR)
        • 5.3.1.2.1. Real-Time PCR (qPCR)
        • 5.3.1.2.2. Digital PCR (dPCR)
        • 5.3.1.2.3. Reverse Transcription PCR (RT-PCR)
      • 5.3.1.3. Microarray Technologies
        • 5.3.1.3.1. DNA Microarrays
        • 5.3.1.3.2. Protein Microarrays
    • 5.3.2. Proteomics Technologies
      • 5.3.2.1. Mass Spectrometry
        • 5.3.2.1.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
        • 5.3.2.1.2. Matrix-Assisted Laser Desorption/Ionization (MALDI)
      • 5.3.2.2. Protein Microarrays
        • 5.3.2.2.1. Antibody Microarrays
        • 5.3.2.2.2. Reverse Phase Protein Microarrays (RPPA)
      • 5.3.2.3. 2D Gel Electrophoresis
        • 5.3.2.3.1. Two-Dimensional Polyacrylamide Gel Electrophoresis (2D PAGE)
        • 5.3.2.3.2. Two-Dimensional Difference Gel Electrophoresis (2D-DIGE)
    • 5.3.3. Imaging Technologies
      • 5.3.3.1. Magnetic Resonance Imaging (MRI)
        • 5.3.3.1.1. Functional MRI (fMRI)
        • 5.3.3.1.2. Diffusion Weighted Imaging (DWI)
      • 5.3.3.2. Computed Tomography (CT)
        • 5.3.3.2.1. Low-Dose CT
        • 5.3.3.2.2. Dual-Energy CT
      • 5.3.3.3. Positron Emission Tomography (PET)
        • 5.3.3.3.1. PET-CT
        • 5.3.3.3.2. PET-MRI
      • 5.3.3.4. Single-Photon Emission Computed Tomography (SPECT)
    • 5.3.4. Liquid Biopsy Technologies
      • 5.3.4.1. Circulating Tumor Cells (CTCs)
        • 5.3.4.1.1. Microfluidic-Based CTC Isolation
        • 5.3.4.1.2. Immunomagnetic CTC Isolation
      • 5.3.4.2. Circulating Tumor DNA (ctDNA)
        • 5.3.4.2.1. Targeted Sequencing of ctDNA
        • 5.3.4.2.2. Methylation-Specific PCR (MSP)
      • 5.3.4.3. Exosomes
        • 5.3.4.3.1. Isolation and Characterization Techniques
        • 5.3.4.3.2. Functional Analysis Methods
    • 5.3.5. Others
      • 5.3.5.1. Flow Cytometry
        • 5.3.5.1.1. Fluorescence-Activated Cell Sorting (FACS)
        • 5.3.5.1.2. Mass Cytometry (CyTOF)
      • 5.3.5.2. In Situ Hybridization (ISH)
        • 5.3.5.2.1. Fluorescence In Situ Hybridization (FISH)
        • 5.3.5.2.2. Chromogenic In Situ Hybridization (CISH)
      • 5.3.5.3. Immunohistochemistry (IHC)
        • 5.3.5.3.1. Multiplex IHC
    • 5.3.6. Digital Pathology IHC

6. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Cancer Diagnosis
      • 6.3.1.1. Early Detection Technologies
        • 6.3.1.1.1. Imaging-Based Early Detection
        • 6.3.1.1.2. Liquid Biopsy for Early Detection
      • 6.3.1.2. Diagnostic Biomarkers
        • 6.3.1.2.1. Genomic Biomarkers
        • 6.3.1.2.2. Proteomic Biomarkers
      • 6.3.1.3. Pathological Diagnosis Advances
        • 6.3.1.3.1. Digital Pathology
        • 6.3.1.3.2. AI-Assisted Pathology
    • 6.3.2. Treatment Selection
      • 6.3.2.1. Precision Medicine Technologies
        • 6.3.2.1.1. Molecular Profiling
        • 6.3.2.1.2. Pharmacogenomics
      • 6.3.2.2. Theranostics Approaches
        • 6.3.2.2.1. Companion Diagnostics
        • 6.3.2.2.2. Predictive Biomarkers
      • 6.3.2.3. Immunotherapy Selection
        • 6.3.2.3.1. Tumor Microenvironment Analysis
        • 6.3.2.3.2. Immune Profiling
    • 6.3.3. Biomarker Discovery
      • 6.3.3.1. Genomic Biomarker Discovery
        • 6.3.3.1.1. Whole Genome Sequencing (WGS) for Biomarkers
        • 6.3.3.1.2. Transcriptomics for Biomarkers
      • 6.3.3.2. Proteomic Biomarker Discovery
        • 6.3.3.2.1. Mass Spectrometry-Based Biomarker Discovery
        • 6.3.3.2.2. Protein Microarray-Based Biomarker Discovery
      • 6.3.3.3. Metabolomics and Metabolic Biomarkers
    • 6.3.4. Therapeutic Development
      • 6.3.4.1. Targeted Therapy Research
        • 6.3.4.1.1. Targeted Drug Discovery
        • 6.3.4.1.2. Immunotherapy Development
      • 6.3.4.2. Drug Efficacy Testing
        • 6.3.4.2.1. In Vitro Testing Methods
        • 6.3.4.2.2. In Vivo Testing Models
      • 6.3.4.3. Gene Therapy and Gene Editing
        • 6.3.4.3.1. CRISPR/Cas9 Applications
        • 6.3.4.3.2. RNA Interference (RNAi) for Cancer
    • 6.3.5. Cancer Epidemiology Research
      • 6.3.5.1. Population-Level Studies
      • 6.3.5.2. Environmental and Lifestyle Factors
      • 6.3.5.3. Cancer Clusters Analysis
    • 6.3.6. Cancer Stem Cell Research
      • 6.3.6.1. Identification and Isolation Techniques
      • 6.3.6.2. Targeted Therapies Against Cancer Stem Cells
    • 6.3.7. Radiation Oncology Advances
      • 6.3.7.1. Precision Radiation Therapy
      • 6.3.7.2. Radiosensitization Strategies
      • 6.3.7.3. Proton Therapy
    • 6.3.8. Functional Genomics in Cancer
      • 6.3.8.1. Functional Genomics Screening
      • 6.3.8.2. CRISPR Functional Genomics
    • 6.3.9. Liquid Biopsy Applications
      • 6.3.9.1. Minimal Residual Disease Monitoring
      • 6.3.9.2. Treatment Response Monitoring
      • 6.3.9.3. Liquid Biopsy for Cancer Subtyping
    • 6.3.10. Health Informatics in Cancer Research
      • 6.3.10.1. Big Data Analytics
      • 6.3.10.2. Electronic Health Records (EHR) Integration
      • 6.3.10.3. Predictive Analytics for Cancer

7. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Bladder
    • 7.3.2. Bone
    • 7.3.3. Brain
    • 7.3.4. Breast
    • 7.3.5. Cancer
    • 7.3.6. Cervical
    • 7.3.7. Cholangiocarcinoma
    • 7.3.8. Colorectal
    • 7.3.9. Haematological
    • 7.3.10. Head and neck
    • 7.3.11. Liver
    • 7.3.12. Lung
    • 7.3.13. Mesothelioma
    • 7.3.14. Ovarian
    • 7.3.15. Pancreatic
    • 7.3.16. Prostate
    • 7.3.17. Renal
    • 7.3.18. Skin
    • 7.3.19. Testicular
    • 7.3.20. Thyroid
    • 7.3.21. Upper gastrointestinal
    • 7.3.22. Multiple cancers
    • 7.3.23. Other

8. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Market Segmentation
    • 8.3.1. Pre-clinical research
    • 8.3.2. Clinical Trials
    • 8.3.3. Public Health Research
    • 8.3.4. Cross-disciplinary research
    • 8.3.5. General cancer research

9. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 9.3. Market Segmentation
    • 9.3.1. Academic and Research Institutions
    • 9.3.2. Pharmaceutical and Biotechnology Companies
    • 9.3.3. Diagnostic Laboratories
    • 9.3.4. Hospitals

10. North America Cancer Research Technologies Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
  • 10.3. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
  • 10.4. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
  • 10.5. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
  • 10.6. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
  • 10.7.Cancer Research Technologies Market: By Region, 2022-2032, USD (Million)
    • 10.7.1.North America
      • 10.7.1.1. U.S.
        • 10.7.1.1.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 10.7.1.1.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 10.7.1.1.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 10.7.1.1.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 10.7.1.1.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 10.7.1.2. Canada
        • 10.7.1.2.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 10.7.1.2.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 10.7.1.2.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 10.7.1.2.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 10.7.1.2.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 10.7.1.3. Rest of North America
        • 10.7.1.3.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 10.7.1.3.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 10.7.1.3.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 10.7.1.3.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 10.7.1.3.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)

11. UK and European Union Cancer Research Technologies Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
  • 11.3. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
  • 11.4. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
  • 11.5. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
  • 11.6. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
  • 11.7.Cancer Research Technologies Market: By Region, 2022-2032, USD (Million)
    • 11.7.1.UK and European Union
      • 11.7.1.1. UK
        • 11.7.1.1.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 11.7.1.1.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 11.7.1.1.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 11.7.1.1.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 11.7.1.1.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 11.7.1.2. Germany
        • 11.7.1.2.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 11.7.1.2.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 11.7.1.2.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 11.7.1.2.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 11.7.1.2.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 11.7.1.3. Spain
        • 11.7.1.3.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 11.7.1.3.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 11.7.1.3.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 11.7.1.3.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 11.7.1.3.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 11.7.1.4. Italy
        • 11.7.1.4.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 11.7.1.4.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 11.7.1.4.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 11.7.1.4.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 11.7.1.4.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 11.7.1.5. France
        • 11.7.1.5.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 11.7.1.5.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 11.7.1.5.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 11.7.1.5.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 11.7.1.5.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 11.7.1.6. Rest of Europe
        • 11.7.1.6.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 11.7.1.6.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 11.7.1.6.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 11.7.1.6.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 11.7.1.6.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)

12. Asia Pacific Cancer Research Technologies Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
  • 12.3. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
  • 12.4. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
  • 12.5. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
  • 12.6. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
  • 12.7.Cancer Research Technologies Market: By Region, 2022-2032, USD (Million)
    • 12.7.1.Asia Pacific
      • 12.7.1.1. China
        • 12.7.1.1.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 12.7.1.1.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 12.7.1.1.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 12.7.1.1.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 12.7.1.1.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 12.7.1.2. Japan
        • 12.7.1.2.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 12.7.1.2.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 12.7.1.2.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 12.7.1.2.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 12.7.1.2.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 12.7.1.3. India
        • 12.7.1.3.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 12.7.1.3.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 12.7.1.3.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 12.7.1.3.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 12.7.1.3.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 12.7.1.4. Australia
        • 12.7.1.4.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 12.7.1.4.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 12.7.1.4.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 12.7.1.4.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 12.7.1.4.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 12.7.1.5. South Korea
        • 12.7.1.5.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 12.7.1.5.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 12.7.1.5.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 12.7.1.5.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 12.7.1.5.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 12.7.1.6. Rest of Asia Pacific
        • 12.7.1.6.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 12.7.1.6.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 12.7.1.6.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 12.7.1.6.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 12.7.1.6.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)

13. Latin America Cancer Research Technologies Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
  • 13.3. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
  • 13.4. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
  • 13.5. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
  • 13.6. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
  • 13.7.Cancer Research Technologies Market: By Region, 2022-2032, USD (Million)
    • 13.7.1.Latin America
      • 13.7.1.1. Brazil
        • 13.7.1.1.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 13.7.1.1.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 13.7.1.1.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 13.7.1.1.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 13.7.1.1.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 13.7.1.2. Mexico
        • 13.7.1.2.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 13.7.1.2.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 13.7.1.2.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 13.7.1.2.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 13.7.1.2.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 13.7.1.3. Rest of Latin America
        • 13.7.1.3.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 13.7.1.3.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 13.7.1.3.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 13.7.1.3.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 13.7.1.3.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)

14. Middle East and Africa Cancer Research Technologies Market, 2022-2032, USD (Million)

  • 14.1. Market Overview
  • 14.2. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
  • 14.3. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
  • 14.4. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
  • 14.5. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
  • 14.6. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
  • 14.7.Cancer Research Technologies Market: By Region, 2022-2032, USD (Million)
    • 14.7.1.Middle East and Africa
      • 14.7.1.1. GCC
        • 14.7.1.1.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 14.7.1.1.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 14.7.1.1.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 14.7.1.1.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 14.7.1.1.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 14.7.1.2. Africa
        • 14.7.1.2.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 14.7.1.2.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 14.7.1.2.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 14.7.1.2.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 14.7.1.2.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)
      • 14.7.1.3. Rest of Middle East and Africa
        • 14.7.1.3.1. Cancer Research Technologies Market: By Technology, 2022-2032, USD (Million)
        • 14.7.1.3.2. Cancer Research Technologies Market: By Research Area, 2022-2032, USD (Million)
        • 14.7.1.3.3. Cancer Research Technologies Market: By Site of Cancer, 2022-2032, USD (Million)
        • 14.7.1.3.4. Cancer Research Technologies Market: By Research Stage, 2022-2032, USD (Million)
        • 14.7.1.3.5. Cancer Research Technologies Market: By End-User, 2022-2032, USD (Million)

15. Company Profile

  • 15.1. Illumina Inc.
    • 15.1.1. Company Overview
    • 15.1.2. Financial Performance
    • 15.1.3. Product Portfolio
    • 15.1.4. Strategic Initiatives
  • 15.2. Thermo Fisher Scientific
    • 15.2.1. Company Overview
    • 15.2.2. Financial Performance
    • 15.2.3. Product Portfolio
    • 15.2.4. Strategic Initiatives
  • 15.3. F. Hoffmann-La Roche AG
    • 15.3.1. Company Overview
    • 15.3.2. Financial Performance
    • 15.3.3. Product Portfolio
    • 15.3.4. Strategic Initiatives
  • 15.4. QIAGEN
    • 15.4.1. Company Overview
    • 15.4.2. Financial Performance
    • 15.4.3. Product Portfolio
    • 15.4.4. Strategic Initiatives
  • 15.5. PerkinElmer Inc.
    • 15.5.1. Company Overview
    • 15.5.2. Financial Performance
    • 15.5.3. Product Portfolio
    • 15.5.4. Strategic Initiatives
  • 15.6. Roche Diagnostics
    • 15.6.1. Company Overview
    • 15.6.2. Financial Performance
    • 15.6.3. Product Portfolio
    • 15.6.4. Strategic Initiatives
  • 15.7. Agilent Technologies
    • 15.7.1. Company Overview
    • 15.7.2. Financial Performance
    • 15.7.3. Product Portfolio
    • 15.7.4. Strategic Initiatives
  • 15.8. Bio-Rad Laboratories
    • 15.8.1. Company Overview
    • 15.8.2. Financial Performance
    • 15.8.3. Product Portfolio
    • 15.8.4. Strategic Initiatives
  • 15.9. Becton, Dickinson and Company (BD)
    • 15.9.1. Company Overview
    • 15.9.2. Financial Performance
    • 15.9.3. Product Portfolio
    • 15.9.4. Strategic Initiatives
  • 15.10. GE Healthcare
    • 15.10.1. Company Overview
    • 15.10.2. Financial Performance
    • 15.10.3. Product Portfolio
    • 15.10.4. Strategic Initiatives
  • 15.11. Siemens Healthineers
    • 15.11.1. Company Overview
    • 15.11.2. Financial Performance
    • 15.11.3. Product Portfolio
    • 15.11.4. Strategic Initiatives
  • 15.12. Abcam
    • 15.12.1. Company Overview
    • 15.12.2. Financial Performance
    • 15.12.3. Product Portfolio
    • 15.12.4. Strategic Initiatives
  • 15.13. GenScript Biotech Corporation
    • 15.13.1. Company Overview
    • 15.13.2. Financial Performance
    • 15.13.3. Product Portfolio
    • 15.13.4. Strategic Initiatives
  • 15.14. Merck KGaA
    • 15.14.1. Company Overview
    • 15.14.2. Financial Performance
    • 15.14.3. Product Portfolio
    • 15.14.4. Strategic Initiatives
  • 15.15. Cell Signaling Technology
    • 15.15.1. Company Overview
    • 15.15.2. Financial Performance
    • 15.15.3. Product Portfolio
    • 15.15.4. Strategic Initiatives
  • 15.16. Sysmex Corporation
    • 15.16.1. Company Overview
    • 15.16.2. Financial Performance
    • 15.16.3. Product Portfolio
    • 15.16.4. Strategic Initiatives
  • 15.17. Other Notable Players
    • 15.17.1. Company Overview
    • 15.17.2. Financial Performance
    • 15.17.3. Product Portfolio
    • 15.17.4. Strategic Initiatives
Show more
Product Code: 140210-04-24

List of Tables

  • TABLE 1 Global Cancer Research Technologies Market By Technology, 2022-2032, USD (Million)
  • TABLE 2 Global Cancer Research Technologies Market By Genomics Technologies, 2022-2032, USD (Million)
  • TABLE 3 Global Cancer Research Technologies Market By Next-Generation Sequencing (NGS), 2022-2032, USD (Million)
  • TABLE 4 Global Cancer Research Technologies Market By Polymerase Chain Reaction (PCR), 2022-2032, USD (Million)
  • TABLE 5 Global Cancer Research Technologies Market By Microarray Technologies, 2022-2032, USD (Million)
  • TABLE 6 Global Cancer Research Technologies Market By Proteomics Technologies, 2022-2032, USD (Million)
  • TABLE 7 Global Cancer Research Technologies Market By Mass Spectrometry, 2022-2032, USD (Million)
  • TABLE 8 Global Cancer Research Technologies Market By Protein Microarrays, 2022-2032, USD (Million)
  • TABLE 9 Global Cancer Research Technologies Market By 2D Gel Electrophoresis, 2022-2032, USD (Million)
  • TABLE 10 Global Cancer Research Technologies Market By Imaging Technologies, 2022-2032, USD (Million)
  • TABLE 11 Global Cancer Research Technologies Market By Magnetic Resonance Imaging (MRI), 2022-2032, USD (Million)
  • TABLE 12 Global Cancer Research Technologies Market By Computed Tomography (CT), 2022-2032, USD (Million)
  • TABLE 13 Global Cancer Research Technologies Market By Positron Emission Tomography (PET), 2022-2032, USD (Million)
  • TABLE 14 Global Cancer Research Technologies Market By Liquid Biopsy Technologies, 2022-2032, USD (Million)
  • TABLE 15 Global Cancer Research Technologies Market By Circulating Tumor Cells (CTCs), 2022-2032, USD (Million)
  • TABLE 16 Global Cancer Research Technologies Market By Circulating Tumor DNA (ctDNA), 2022-2032, USD (Million)
  • TABLE 17 Global Cancer Research Technologies Market By Exosomes, 2022-2032, USD (Million)
  • TABLE 18 Global Cancer Research Technologies Market By Others, 2022-2032, USD (Million)
  • TABLE 19 Global Cancer Research Technologies Market By Flow Cytometry, 2022-2032, USD (Million)
  • TABLE 20 Global Cancer Research Technologies Market By In Situ Hybridization (ISH), 2022-2032, USD (Million)
  • TABLE 21 Global Cancer Research Technologies Market By Immunohistochemistry (IHC), 2022-2032, USD (Million)
  • TABLE 22 Global Cancer Research Technologies Market By Research Area, 2022-2032, USD (Million)
  • TABLE 23 Global Cancer Research Technologies Market By Cancer Diagnosis, 2022-2032, USD (Million)
  • TABLE 24 Global Cancer Research Technologies Market By Early Detection Technologies, 2022-2032, USD (Million)
  • TABLE 25 Global Cancer Research Technologies Market By Diagnostic Biomarkers, 2022-2032, USD (Million)
  • TABLE 26 Global Cancer Research Technologies Market By Pathological Diagnosis Advances, 2022-2032, USD (Million)
  • TABLE 27 Global Cancer Research Technologies Market By Treatment Selection, 2022-2032, USD (Million)
  • TABLE 28 Global Cancer Research Technologies Market By Precision Medicine Technologies, 2022-2032, USD (Million)
  • TABLE 29 Global Cancer Research Technologies Market By Theranostics Approaches, 2022-2032, USD (Million)
  • TABLE 30 Global Cancer Research Technologies Market By Immunotherapy Selection, 2022-2032, USD (Million)
  • TABLE 31 Global Cancer Research Technologies Market By Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 32 Global Cancer Research Technologies Market By Genomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 33 Global Cancer Research Technologies Market By Proteomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 34 Global Cancer Research Technologies Market By Therapeutic Development, 2022-2032, USD (Million)
  • TABLE 35 Global Cancer Research Technologies Market By Targeted Therapy Research, 2022-2032, USD (Million)
  • TABLE 36 Global Cancer Research Technologies Market By Drug Efficacy Testing, 2022-2032, USD (Million)
  • TABLE 37 Global Cancer Research Technologies Market By Gene Therapy and Gene Editing, 2022-2032, USD (Million)
  • TABLE 38 Global Cancer Research Technologies Market By Cancer Epidemiology Research, 2022-2032, USD (Million)
  • TABLE 39 Global Cancer Research Technologies Market By Cancer Stem Cell Research, 2022-2032, USD (Million)
  • TABLE 40 Global Cancer Research Technologies Market By Radiation Oncology Advances, 2022-2032, USD (Million)
  • TABLE 41 Global Cancer Research Technologies Market By Functional Genomics in Cancer, 2022-2032, USD (Million)
  • TABLE 42 Global Cancer Research Technologies Market By Liquid Biopsy Applications, 2022-2032, USD (Million)
  • TABLE 43 Global Cancer Research Technologies Market By Health Informatics in Cancer Research, 2022-2032, USD (Million)
  • TABLE 44 Global Cancer Research Technologies Market By Site of Cancer, 2022-2032, USD (Million)
  • TABLE 45 Global Cancer Research Technologies Market By Research Stage, 2022-2032, USD (Million)
  • TABLE 46 Global Cancer Research Technologies Market By End-User, 2022-2032, USD (Million)
  • TABLE 47 North America Cancer Research Technologies Market By Technology, 2022-2032, USD (Million)
  • TABLE 48 North America Cancer Research Technologies Market By Genomics Technologies, 2022-2032, USD (Million)
  • TABLE 49 North America Cancer Research Technologies Market By Next-Generation Sequencing (NGS), 2022-2032, USD (Million)
  • TABLE 50 North America Cancer Research Technologies Market By Polymerase Chain Reaction (PCR), 2022-2032, USD (Million)
  • TABLE 51 North America Cancer Research Technologies Market By Microarray Technologies, 2022-2032, USD (Million)
  • TABLE 52 North America Cancer Research Technologies Market By Proteomics Technologies, 2022-2032, USD (Million)
  • TABLE 53 North America Cancer Research Technologies Market By Mass Spectrometry, 2022-2032, USD (Million)
  • TABLE 54 North America Cancer Research Technologies Market By Protein Microarrays, 2022-2032, USD (Million)
  • TABLE 55 North America Cancer Research Technologies Market By 2D Gel Electrophoresis, 2022-2032, USD (Million)
  • TABLE 56 North America Cancer Research Technologies Market By Imaging Technologies, 2022-2032, USD (Million)
  • TABLE 57 North America Cancer Research Technologies Market By Magnetic Resonance Imaging (MRI), 2022-2032, USD (Million)
  • TABLE 58 North America Cancer Research Technologies Market By Computed Tomography (CT), 2022-2032, USD (Million)
  • TABLE 59 North America Cancer Research Technologies Market By Positron Emission Tomography (PET), 2022-2032, USD (Million)
  • TABLE 60 North America Cancer Research Technologies Market By Liquid Biopsy Technologies, 2022-2032, USD (Million)
  • TABLE 61 North America Cancer Research Technologies Market By Circulating Tumor Cells (CTCs), 2022-2032, USD (Million)
  • TABLE 62 North America Cancer Research Technologies Market By Circulating Tumor DNA (ctDNA), 2022-2032, USD (Million)
  • TABLE 63 North America Cancer Research Technologies Market By Exosomes, 2022-2032, USD (Million)
  • TABLE 64 North America Cancer Research Technologies Market By Others, 2022-2032, USD (Million)
  • TABLE 65 North America Cancer Research Technologies Market By Flow Cytometry, 2022-2032, USD (Million)
  • TABLE 66 North America Cancer Research Technologies Market By In Situ Hybridization (ISH), 2022-2032, USD (Million)
  • TABLE 67 North America Cancer Research Technologies Market By Immunohistochemistry (IHC), 2022-2032, USD (Million)
  • TABLE 68 North America Cancer Research Technologies Market By Research Area, 2022-2032, USD (Million)
  • TABLE 69 North America Cancer Research Technologies Market By Cancer Diagnosis, 2022-2032, USD (Million)
  • TABLE 70 North America Cancer Research Technologies Market By Early Detection Technologies, 2022-2032, USD (Million)
  • TABLE 71 North America Cancer Research Technologies Market By Diagnostic Biomarkers, 2022-2032, USD (Million)
  • TABLE 72 North America Cancer Research Technologies Market By Pathological Diagnosis Advances, 2022-2032, USD (Million)
  • TABLE 73 North America Cancer Research Technologies Market By Treatment Selection, 2022-2032, USD (Million)
  • TABLE 74 North America Cancer Research Technologies Market By Precision Medicine Technologies, 2022-2032, USD (Million)
  • TABLE 75 North America Cancer Research Technologies Market By Theranostics Approaches, 2022-2032, USD (Million)
  • TABLE 76 North America Cancer Research Technologies Market By Immunotherapy Selection, 2022-2032, USD (Million)
  • TABLE 77 North America Cancer Research Technologies Market By Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 78 North America Cancer Research Technologies Market By Genomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 79 North America Cancer Research Technologies Market By Proteomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 80 North America Cancer Research Technologies Market By Therapeutic Development, 2022-2032, USD (Million)
  • TABLE 81 North America Cancer Research Technologies Market By Targeted Therapy Research, 2022-2032, USD (Million)
  • TABLE 82 North America Cancer Research Technologies Market By Drug Efficacy Testing, 2022-2032, USD (Million)
  • TABLE 83 North America Cancer Research Technologies Market By Gene Therapy and Gene Editing, 2022-2032, USD (Million)
  • TABLE 84 North America Cancer Research Technologies Market By Cancer Epidemiology Research, 2022-2032, USD (Million)
  • TABLE 85 North America Cancer Research Technologies Market By Cancer Stem Cell Research, 2022-2032, USD (Million)
  • TABLE 86 North America Cancer Research Technologies Market By Radiation Oncology Advances, 2022-2032, USD (Million)
  • TABLE 87 North America Cancer Research Technologies Market By Functional Genomics in Cancer, 2022-2032, USD (Million)
  • TABLE 88 North America Cancer Research Technologies Market By Liquid Biopsy Applications, 2022-2032, USD (Million)
  • TABLE 89 North America Cancer Research Technologies Market By Health Informatics in Cancer Research, 2022-2032, USD (Million)
  • TABLE 90 North America Cancer Research Technologies Market By Site of Cancer, 2022-2032, USD (Million)
  • TABLE 91 North America Cancer Research Technologies Market By Research Stage, 2022-2032, USD (Million)
  • TABLE 92 North America Cancer Research Technologies Market By End-User, 2022-2032, USD (Million)
  • TABLE 93 UK and European Union Cancer Research Technologies Market By Technology, 2022-2032, USD (Million)
  • TABLE 94 UK and European Union Cancer Research Technologies Market By Genomics Technologies, 2022-2032, USD (Million)
  • TABLE 95 UK and European Union Cancer Research Technologies Market By Next-Generation Sequencing (NGS), 2022-2032, USD (Million)
  • TABLE 96 UK and European Union Cancer Research Technologies Market By Polymerase Chain Reaction (PCR), 2022-2032, USD (Million)
  • TABLE 97 UK and European Union Cancer Research Technologies Market By Microarray Technologies, 2022-2032, USD (Million)
  • TABLE 98 UK and European Union Cancer Research Technologies Market By Proteomics Technologies, 2022-2032, USD (Million)
  • TABLE 99 UK and European Union Cancer Research Technologies Market By Mass Spectrometry, 2022-2032, USD (Million)
  • TABLE 100 UK and European Union Cancer Research Technologies Market By Protein Microarrays, 2022-2032, USD (Million)
  • TABLE 101 UK and European Union Cancer Research Technologies Market By 2D Gel Electrophoresis, 2022-2032, USD (Million)
  • TABLE 102 UK and European Union Cancer Research Technologies Market By Imaging Technologies, 2022-2032, USD (Million)
  • TABLE 103 UK and European Union Cancer Research Technologies Market By Magnetic Resonance Imaging (MRI), 2022-2032, USD (Million)
  • TABLE 104 UK and European Union Cancer Research Technologies Market By Computed Tomography (CT), 2022-2032, USD (Million)
  • TABLE 105 UK and European Union Cancer Research Technologies Market By Positron Emission Tomography (PET), 2022-2032, USD (Million)
  • TABLE 106 UK and European Union Cancer Research Technologies Market By Liquid Biopsy Technologies, 2022-2032, USD (Million)
  • TABLE 107 UK and European Union Cancer Research Technologies Market By Circulating Tumor Cells (CTCs), 2022-2032, USD (Million)
  • TABLE 108 UK and European Union Cancer Research Technologies Market By Circulating Tumor DNA (ctDNA), 2022-2032, USD (Million)
  • TABLE 109 UK and European Union Cancer Research Technologies Market By Exosomes, 2022-2032, USD (Million)
  • TABLE 110 UK and European Union Cancer Research Technologies Market By Others, 2022-2032, USD (Million)
  • TABLE 111 UK and European Union Cancer Research Technologies Market By Flow Cytometry, 2022-2032, USD (Million)
  • TABLE 112 UK and European Union Cancer Research Technologies Market By In Situ Hybridization (ISH), 2022-2032, USD (Million)
  • TABLE 113 UK and European Union Cancer Research Technologies Market By Immunohistochemistry (IHC), 2022-2032, USD (Million)
  • TABLE 114 UK and European Union Cancer Research Technologies Market By Research Area, 2022-2032, USD (Million)
  • TABLE 115 UK and European Union Cancer Research Technologies Market By Cancer Diagnosis, 2022-2032, USD (Million)
  • TABLE 116 UK and European Union Cancer Research Technologies Market By Early Detection Technologies, 2022-2032, USD (Million)
  • TABLE 117 UK and European Union Cancer Research Technologies Market By Diagnostic Biomarkers, 2022-2032, USD (Million)
  • TABLE 118 UK and European Union Cancer Research Technologies Market By Pathological Diagnosis Advances, 2022-2032, USD (Million)
  • TABLE 119 UK and European Union Cancer Research Technologies Market By Treatment Selection, 2022-2032, USD (Million)
  • TABLE 120 UK and European Union Cancer Research Technologies Market By Precision Medicine Technologies, 2022-2032, USD (Million)
  • TABLE 121 UK and European Union Cancer Research Technologies Market By Theranostics Approaches, 2022-2032, USD (Million)
  • TABLE 122 UK and European Union Cancer Research Technologies Market By Immunotherapy Selection, 2022-2032, USD (Million)
  • TABLE 123 UK and European Union Cancer Research Technologies Market By Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 124 UK and European Union Cancer Research Technologies Market By Genomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 125 UK and European Union Cancer Research Technologies Market By Proteomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 126 UK and European Union Cancer Research Technologies Market By Therapeutic Development, 2022-2032, USD (Million)
  • TABLE 127 UK and European Union Cancer Research Technologies Market By Targeted Therapy Research, 2022-2032, USD (Million)
  • TABLE 128 UK and European Union Cancer Research Technologies Market By Drug Efficacy Testing, 2022-2032, USD (Million)
  • TABLE 129 UK and European Union Cancer Research Technologies Market By Gene Therapy and Gene Editing, 2022-2032, USD (Million)
  • TABLE 130 UK and European Union Cancer Research Technologies Market By Cancer Epidemiology Research, 2022-2032, USD (Million)
  • TABLE 131 UK and European Union Cancer Research Technologies Market By Cancer Stem Cell Research, 2022-2032, USD (Million)
  • TABLE 132 UK and European Union Cancer Research Technologies Market By Radiation Oncology Advances, 2022-2032, USD (Million)
  • TABLE 133 UK and European Union Cancer Research Technologies Market By Functional Genomics in Cancer, 2022-2032, USD (Million)
  • TABLE 134 UK and European Union Cancer Research Technologies Market By Liquid Biopsy Applications, 2022-2032, USD (Million)
  • TABLE 135 UK and European Union Cancer Research Technologies Market By Health Informatics in Cancer Research, 2022-2032, USD (Million)
  • TABLE 136 UK and European Union Cancer Research Technologies Market By Site of Cancer, 2022-2032, USD (Million)
  • TABLE 137 UK and European Union Cancer Research Technologies Market By Research Stage, 2022-2032, USD (Million)
  • TABLE 138 UK and European Union Cancer Research Technologies Market By End-User, 2022-2032, USD (Million)
  • TABLE 139 Asia Cancer Research Technologies Market By Technology, 2022-2032, USD (Million)
  • TABLE 140 Asia Cancer Research Technologies Market By Genomics Technologies, 2022-2032, USD (Million)
  • TABLE 141 Asia Cancer Research Technologies Market By Next-Generation Sequencing (NGS), 2022-2032, USD (Million)
  • TABLE 142 Asia Cancer Research Technologies Market By Polymerase Chain Reaction (PCR), 2022-2032, USD (Million)
  • TABLE 143 Asia Cancer Research Technologies Market By Microarray Technologies, 2022-2032, USD (Million)
  • TABLE 144 Asia Cancer Research Technologies Market By Proteomics Technologies, 2022-2032, USD (Million)
  • TABLE 145 Asia Cancer Research Technologies Market By Mass Spectrometry, 2022-2032, USD (Million)
  • TABLE 146 Asia Cancer Research Technologies Market By Protein Microarrays, 2022-2032, USD (Million)
  • TABLE 147 Asia Cancer Research Technologies Market By 2D Gel Electrophoresis, 2022-2032, USD (Million)
  • TABLE 148 Asia Cancer Research Technologies Market By Imaging Technologies, 2022-2032, USD (Million)
  • TABLE 149 Asia Cancer Research Technologies Market By Magnetic Resonance Imaging (MRI), 2022-2032, USD (Million)
  • TABLE 150 Asia Cancer Research Technologies Market By Computed Tomography (CT), 2022-2032, USD (Million)
  • TABLE 151 Asia Cancer Research Technologies Market By Positron Emission Tomography (PET), 2022-2032, USD (Million)
  • TABLE 152 Asia Cancer Research Technologies Market By Liquid Biopsy Technologies, 2022-2032, USD (Million)
  • TABLE 153 Asia Cancer Research Technologies Market By Circulating Tumor Cells (CTCs), 2022-2032, USD (Million)
  • TABLE 154 Asia Cancer Research Technologies Market By Circulating Tumor DNA (ctDNA), 2022-2032, USD (Million)
  • TABLE 155 Asia Cancer Research Technologies Market By Exosomes, 2022-2032, USD (Million)
  • TABLE 156 Asia Cancer Research Technologies Market By Others, 2022-2032, USD (Million)
  • TABLE 157 Asia Cancer Research Technologies Market By Flow Cytometry, 2022-2032, USD (Million)
  • TABLE 158 Asia Cancer Research Technologies Market By In Situ Hybridization (ISH), 2022-2032, USD (Million)
  • TABLE 159 Asia Cancer Research Technologies Market By Immunohistochemistry (IHC), 2022-2032, USD (Million)
  • TABLE 160 Asia Cancer Research Technologies Market By Research Area, 2022-2032, USD (Million)
  • TABLE 161 Asia Cancer Research Technologies Market By Cancer Diagnosis, 2022-2032, USD (Million)
  • TABLE 162 Asia Cancer Research Technologies Market By Early Detection Technologies, 2022-2032, USD (Million)
  • TABLE 163 Asia Cancer Research Technologies Market By Diagnostic Biomarkers, 2022-2032, USD (Million)
  • TABLE 164 Asia Cancer Research Technologies Market By Pathological Diagnosis Advances, 2022-2032, USD (Million)
  • TABLE 165 Asia Cancer Research Technologies Market By Treatment Selection, 2022-2032, USD (Million)
  • TABLE 166 Asia Cancer Research Technologies Market By Precision Medicine Technologies, 2022-2032, USD (Million)
  • TABLE 167 Asia Cancer Research Technologies Market By Theranostics Approaches, 2022-2032, USD (Million)
  • TABLE 168 Asia Cancer Research Technologies Market By Immunotherapy Selection, 2022-2032, USD (Million)
  • TABLE 169 Asia Cancer Research Technologies Market By Biomarker Discovery, 2022-2032, USD (Million)

TABLE 170Asia Cancer Research Technologies Market By Genomic Biomarker Discovery, 2022-2032, USD (Million)

  • TABLE 171 Asia Cancer Research Technologies Market By Proteomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 172 Asia Cancer Research Technologies Market By Therapeutic Development, 2022-2032, USD (Million)
  • TABLE 173 Asia Cancer Research Technologies Market By Targeted Therapy Research, 2022-2032, USD (Million)
  • TABLE 174 Asia Cancer Research Technologies Market By Drug Efficacy Testing, 2022-2032, USD (Million)
  • TABLE 175 Asia Cancer Research Technologies Market By Gene Therapy and Gene Editing, 2022-2032, USD (Million)
  • TABLE 176 Asia Cancer Research Technologies Market By Cancer Epidemiology Research, 2022-2032, USD (Million)
  • TABLE 177 Asia Cancer Research Technologies Market By Cancer Stem Cell Research, 2022-2032, USD (Million)
  • TABLE 178 Asia Cancer Research Technologies Market By Radiation Oncology Advances, 2022-2032, USD (Million)
  • TABLE 179 Asia Cancer Research Technologies Market By Functional Genomics in Cancer, 2022-2032, USD (Million)
  • TABLE 180 Asia Cancer Research Technologies Market By Liquid Biopsy Applications, 2022-2032, USD (Million)
  • TABLE 181 Asia Cancer Research Technologies Market By Health Informatics in Cancer Research, 2022-2032, USD (Million)
  • TABLE 182 Asia Cancer Research Technologies Market By Site of Cancer, 2022-2032, USD (Million)
  • TABLE 183 Asia Cancer Research Technologies Market By Research Stage, 2022-2032, USD (Million)
  • TABLE 184 Asia Cancer Research Technologies Market By End-User, 2022-2032, USD (Million)
  • TABLE 185 Latin America Cancer Research Technologies Market By Technology, 2022-2032, USD (Million)
  • TABLE 186 Latin America Cancer Research Technologies Market By Genomics Technologies, 2022-2032, USD (Million)
  • TABLE 187 Latin America Cancer Research Technologies Market By Next-Generation Sequencing (NGS), 2022-2032, USD (Million)
  • TABLE 188 Latin America Cancer Research Technologies Market By Polymerase Chain Reaction (PCR), 2022-2032, USD (Million)
  • TABLE 189 Latin America Cancer Research Technologies Market By Microarray Technologies, 2022-2032, USD (Million)
  • TABLE 190 Latin America Cancer Research Technologies Market By Proteomics Technologies, 2022-2032, USD (Million)
  • TABLE 191 Latin America Cancer Research Technologies Market By Mass Spectrometry, 2022-2032, USD (Million)
  • TABLE 192 Latin America Cancer Research Technologies Market By Protein Microarrays, 2022-2032, USD (Million)
  • TABLE 193 Latin America Cancer Research Technologies Market By 2D Gel Electrophoresis, 2022-2032, USD (Million)
  • TABLE 194 Latin America Cancer Research Technologies Market By Imaging Technologies, 2022-2032, USD (Million)
  • TABLE 195 Latin America Cancer Research Technologies Market By Magnetic Resonance Imaging (MRI), 2022-2032, USD (Million)
  • TABLE 196 Latin America Cancer Research Technologies Market By Computed Tomography (CT), 2022-2032, USD (Million)
  • TABLE 197 Latin America Cancer Research Technologies Market By Positron Emission Tomography (PET), 2022-2032, USD (Million)
  • TABLE 198 Latin America Cancer Research Technologies Market By Liquid Biopsy Technologies, 2022-2032, USD (Million)
  • TABLE 199 Latin America Cancer Research Technologies Market By Circulating Tumor Cells (CTCs), 2022-2032, USD (Million)
  • TABLE 200 Latin America Cancer Research Technologies Market By Circulating Tumor DNA (ctDNA), 2022-2032, USD (Million)
  • TABLE 201 Latin America Cancer Research Technologies Market By Exosomes, 2022-2032, USD (Million)
  • TABLE 202 Latin America Cancer Research Technologies Market By Others, 2022-2032, USD (Million)
  • TABLE 203 Latin America Cancer Research Technologies Market By Flow Cytometry, 2022-2032, USD (Million)
  • TABLE 204 Latin America Cancer Research Technologies Market By In Situ Hybridization (ISH), 2022-2032, USD (Million)
  • TABLE 205 Latin America Cancer Research Technologies Market By Immunohistochemistry (IHC), 2022-2032, USD (Million)
  • TABLE 206 Latin America Cancer Research Technologies Market By Research Area, 2022-2032, USD (Million)
  • TABLE 207 Latin America Cancer Research Technologies Market By Cancer Diagnosis, 2022-2032, USD (Million)
  • TABLE 208 Latin America Cancer Research Technologies Market By Early Detection Technologies, 2022-2032, USD (Million)
  • TABLE 209 Latin America Cancer Research Technologies Market By Diagnostic Biomarkers, 2022-2032, USD (Million)
  • TABLE 210 Latin America Cancer Research Technologies Market By Pathological Diagnosis Advances, 2022-2032, USD (Million)
  • TABLE 211 Latin America Cancer Research Technologies Market By Treatment Selection, 2022-2032, USD (Million)
  • TABLE 212 Latin America Cancer Research Technologies Market By Precision Medicine Technologies, 2022-2032, USD (Million)
  • TABLE 212 Latin America Cancer Research Technologies Market By Theranostics Approaches, 2022-2032, USD (Million)
  • TABLE 213 Latin America Cancer Research Technologies Market By Immunotherapy Selection, 2022-2032, USD (Million)
  • TABLE 214 Latin America Cancer Research Technologies Market By Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 215 Latin America Cancer Research Technologies Market By Genomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 216 Latin America Cancer Research Technologies Market By Proteomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 217 Latin America Cancer Research Technologies Market By Therapeutic Development, 2022-2032, USD (Million)
  • TABLE 218 Latin America Cancer Research Technologies Market By Targeted Therapy Research, 2022-2032, USD (Million)
  • TABLE 219 Latin America Cancer Research Technologies Market By Drug Efficacy Testing, 2022-2032, USD (Million)
  • TABLE 220 Latin America Cancer Research Technologies Market By Gene Therapy and Gene Editing, 2022-2032, USD (Million)
  • TABLE 221 Latin America Cancer Research Technologies Market By Cancer Epidemiology Research, 2022-2032, USD (Million)
  • TABLE 222 Latin America Cancer Research Technologies Market By Cancer Stem Cell Research, 2022-2032, USD (Million)
  • TABLE 223 Latin America Cancer Research Technologies Market By Radiation Oncology Advances, 2022-2032, USD (Million)
  • TABLE 224 Latin America Cancer Research Technologies Market By Functional Genomics in Cancer, 2022-2032, USD (Million)
  • TABLE 225 Latin America Cancer Research Technologies Market By Liquid Biopsy Applications, 2022-2032, USD (Million)
  • TABLE 226 Latin America Cancer Research Technologies Market By Health Informatics in Cancer Research, 2022-2032, USD (Million)
  • TABLE 227 Latin America Cancer Research Technologies Market By Site of Cancer, 2022-2032, USD (Million)
  • TABLE 228 Latin America Cancer Research Technologies Market By Research Stage, 2022-2032, USD (Million)
  • TABLE 229 Latin America Cancer Research Technologies Market By End-User, 2022-2032, USD (Million)
  • TABLE 230 Middle East and Africa Cancer Research Technologies Market By Technology, 2022-2032, USD (Million)
  • TABLE 231 Middle East and Africa Cancer Research Technologies Market By Genomics Technologies, 2022-2032, USD (Million)
  • TABLE 232 Middle East and Africa Cancer Research Technologies Market By Next-Generation Sequencing (NGS), 2022-2032, USD (Million)
  • TABLE 233 Middle East and Africa Cancer Research Technologies Market By Polymerase Chain Reaction (PCR), 2022-2032, USD (Million)
  • TABLE 234 Middle East and Africa Cancer Research Technologies Market By Microarray Technologies, 2022-2032, USD (Million)
  • TABLE 235 Middle East and Africa Cancer Research Technologies Market By Proteomics Technologies, 2022-2032, USD (Million)
  • TABLE 236 Middle East and Africa Cancer Research Technologies Market By Mass Spectrometry, 2022-2032, USD (Million)
  • TABLE 237 Middle East and Africa Cancer Research Technologies Market By Protein Microarrays, 2022-2032, USD (Million)
  • TABLE 238 Middle East and Africa Cancer Research Technologies Market By 2D Gel Electrophoresis, 2022-2032, USD (Million)
  • TABLE 239 Middle East and Africa Cancer Research Technologies Market By Imaging Technologies, 2022-2032, USD (Million)
  • TABLE 240 Middle East and Africa Cancer Research Technologies Market By Magnetic Resonance Imaging (MRI), 2022-2032, USD (Million)
  • TABLE 241 Middle East and Africa Cancer Research Technologies Market By Computed Tomography (CT), 2022-2032, USD (Million)
  • TABLE 242 Middle East and Africa Cancer Research Technologies Market By Positron Emission Tomography (PET), 2022-2032, USD (Million)
  • TABLE 243 Middle East and Africa Cancer Research Technologies Market By Liquid Biopsy Technologies, 2022-2032, USD (Million)
  • TABLE 244 Middle East and Africa Cancer Research Technologies Market By Circulating Tumor Cells (CTCs), 2022-2032, USD (Million)
  • TABLE 245 Middle East and Africa Cancer Research Technologies Market By Circulating Tumor DNA (ctDNA), 2022-2032, USD (Million)
  • TABLE 246 Middle East and Africa Cancer Research Technologies Market By Exosomes, 2022-2032, USD (Million)
  • TABLE 247 Middle East and Africa Cancer Research Technologies Market By Others, 2022-2032, USD (Million)
  • TABLE 248 Middle East and Africa Cancer Research Technologies Market By Flow Cytometry, 2022-2032, USD (Million)
  • TABLE 249 Middle East and Africa Cancer Research Technologies Market By In Situ Hybridization (ISH), 2022-2032, USD (Million)
  • TABLE 250 Middle East and Africa Cancer Research Technologies Market By Immunohistochemistry (IHC), 2022-2032, USD (Million)
  • TABLE 251 Middle East and Africa Cancer Research Technologies Market By Research Area, 2022-2032, USD (Million)
  • TABLE 252 Middle East and Africa Cancer Research Technologies Market By Cancer Diagnosis, 2022-2032, USD (Million)
  • TABLE 253 Middle East and Africa Cancer Research Technologies Market By Early Detection Technologies, 2022-2032, USD (Million)
  • TABLE 254 Middle East and Africa Cancer Research Technologies Market By Diagnostic Biomarkers, 2022-2032, USD (Million)
  • TABLE 255 Middle East and Africa Cancer Research Technologies Market By Pathological Diagnosis Advances, 2022-2032, USD (Million)
  • TABLE 256 Middle East and Africa Cancer Research Technologies Market By Treatment Selection, 2022-2032, USD (Million)
  • TABLE 257 Middle East and Africa Cancer Research Technologies Market By Precision Medicine Technologies, 2022-2032, USD (Million)
  • TABLE 258 Middle East and Africa Cancer Research Technologies Market By Theranostics Approaches, 2022-2032, USD (Million)
  • TABLE 259 Middle East and Africa Cancer Research Technologies Market By Immunotherapy Selection, 2022-2032, USD (Million)
  • TABLE 260 Middle East and Africa Cancer Research Technologies Market By Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 261 Middle East and Africa Cancer Research Technologies Market By Genomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 262 Middle East and Africa Cancer Research Technologies Market By Proteomic Biomarker Discovery, 2022-2032, USD (Million)
  • TABLE 263 Middle East and Africa Cancer Research Technologies Market By Therapeutic Development, 2022-2032, USD (Million)
  • TABLE 264 Middle East and Africa Cancer Research Technologies Market By Targeted Therapy Research, 2022-2032, USD (Million)
  • TABLE 265 Middle East and Africa Cancer Research Technologies Market By Drug Efficacy Testing, 2022-2032, USD (Million)
  • TABLE 266 Middle East and Africa Cancer Research Technologies Market By Gene Therapy and Gene Editing, 2022-2032, USD (Million)
  • TABLE 267 Middle East and Africa Cancer Research Technologies Market By Cancer Epidemiology Research, 2022-2032, USD (Million)
  • TABLE 268 Middle East and Africa Cancer Research Technologies Market By Cancer Stem Cell Research, 2022-2032, USD (Million)
  • TABLE 269 Middle East and Africa Cancer Research Technologies Market By Radiation Oncology Advances, 2022-2032, USD (Million)
  • TABLE 270 Middle East and Africa Cancer Research Technologies Market By Functional Genomics in Cancer, 2022-2032, USD (Million)
  • TABLE 271 Middle East and Africa Cancer Research Technologies Market By Liquid Biopsy Applications, 2022-2032, USD (Million)
  • TABLE 272 Middle East and Africa Cancer Research Technologies Market By Health Informatics in Cancer Research, 2022-2032, USD (Million)
  • TABLE 273 Middle East and Africa Cancer Research Technologies Market By Site of Cancer, 2022-2032, USD (Million)
  • TABLE 274 Middle East and Africa Cancer Research Technologies Market By Research Stage, 2022-2032, USD (Million)
  • TABLE 275 Middle East and Africa Cancer Research Technologies Market By End-User, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Cancer Research Technologies Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Cancer Research Technologies Market: Quality Assurance
  • FIG. 5 Global Cancer Research Technologies Market, By Technology, 2023
  • FIG. 6 Global Cancer Research Technologies Market, By Research Area, 2023
  • FIG. 7 Global Cancer Research Technologies Market, By Site of Cancer, 2023
  • FIG. 8 Global Cancer Research Technologies Market, By Research Stage, 2023
  • FIG. 9 Global Cancer Research Technologies Market, By End-User, 2023
  • FIG. 10 Global Cancer Research Technologies Market, By Geography, 2023
  • FIG. 11 Market Geographical Opportunity Matrix - Global Cancer Research Technologies Market, 2023

FIG. 12Market Positioning of Key Cancer Research Technologies Market Players, 2023

FIG. 13Global Cancer Research Technologies Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 14 Global Cancer Research Technologies Market, By Technology, 2023 Vs 2032, %
  • FIG. 15 Global Cancer Research Technologies Market, By Research Area, 2023 Vs 2032, %
  • FIG. 16 Global Cancer Research Technologies Market, By Site of Cancer, 2023 Vs 2032, %
  • FIG. 17 Global Cancer Research Technologies Market, By Research Stage, 2023 Vs 2032, %
  • FIG. 18 Global Cancer Research Technologies Market, By End-User, 2023 Vs 2032, %
  • FIG. 19 U.S. Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 20 Canada Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of North America Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 22 UK Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 23 Germany Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 24 Spain Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 25 Italy Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 26 France Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Europe Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 28 China Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 29 Japan Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 30 India Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 31 Australia Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 32 South Korea Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Asia Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 34 Brazil Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 35 Mexico Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 36 Rest of Latin America Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 37 GCC Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 38 Africa Cancer Research Technologies Market (US$ Million), 2022 - 2032
  • FIG. 39 Rest of Middle East and Africa Cancer Research Technologies Market (US$ Million), 2022 - 2032
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!